Last deal

$9.23M
Local Amount - EUR 8.5M

Amount

Seed

Stage

22.05.2024

Date

1

all rounds

$9.23M

Total amount

Financing round

General

About Company
Captain T Cell is a start-up project focused on developing T cell-based immunotherapies for cancer patients.

Industry

Sector :

Subsector :

Last funding type

Seed

IPO status

Private

Description

The company specializes in identifying innovative and highly effective TCRs (T cell receptors) to create advanced T cell immunotherapies. With a primary focus on CMC (Chemistry, Manufacturing, and Controls) and preclinical development, Captain T Cell is dedicated to advancing their leading candidates. Their mission is to revolutionize cancer treatment by harnessing the power of T cells to combat the disease and improve patient outcomes.
Contacts
Similar Companies
1000
Kite Pharma

Kite Pharma

Kite, a Gilead Company, focuses on cell therapy to cure cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Financial Services

Location

Los Angeles, CA, USA

total rounds

5

total raised

$335.38M

count Of Investments

12

count Of Exists

1
Asgard Therapeutics

Asgard Therapeutics

Asgard Therapeutics is a biotech company developing cancer immunotherapies through direct cell reprogramming.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Lund, Sweden

total rounds

3

total raised

$39.78M

Escend Pharmaceuticals, Inc.

Escend is a company developing therapeutics that target cancer stem cells.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Menlo Park, CA, USA
Shoreline Biosciences

Shoreline Biosciences

Shoreline Biosciences is a biomedical company developing immunotherapies for seriously ill patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

La Jolla, San Diego, CA, USA

total rounds

3

total raised

$186M

Financials

Funding Rounds
1
1

Number of Funding Rounds

$9.23M

Money Raised

Their latest funding was raised on 22.05.2024. Their latest investor Brandenburg Kapital. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
22.05.2024
3
$9.23M
Local Amount - EUR 8.5M
Co-Investors
Investors
3
0

Number of lead investors

3

Number of investors

Brandenburg Kapital

Brandenburg Kapital

Brandenburg Kapital is a venture capital firm that invests in technology-oriented companies throughout their entire life-cycle.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Potsdam, Germany

count Of Investments

59

count Of Exists

3

Hao Nam Nguyen

Hao Nam Nguyen is the Investment Manager at Brandenburg Kapital.

Hil-Invent

Hil-Invent is an investment firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance

count Of Investments

4

Friedrich Hillebrand

i&i Biotech Fund

i&i Biotech Fund

i&i Bio is a Luxembourg-based venture capital firm investing in European Life Sciences.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Biotechnology, Venture Capital, Health Care

Location

Bonnevoie, 2543 Luxembourg

count Of Investments

9
Jaromír Zahrádka

Jaromír Zahrádka

Jaromír Zahrádka CEO and Managing Partner of i&i Biotech Fund.

People

Employee Profiles
1
Rainer Stahn

Rainer Stahn

Scientist

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week